50. RISK OF TRACT RECURRENCE WITH STEREOTACTIC BIOPSY OF BRAIN METASTASES: AN 18-YEAR CANCER CENTER EXPERIENCE

BACKGROUND: Stereotactic biopsy is increasingly performed on brain metastases (BrM) as improving cancer outcomes drive aggressive multimodality treatment, however the risk of tract recurrence for such biopsies, in both the upfront and recurrent settings, are poorly defined in an era defined by focus...

Descripción completa

Detalles Bibliográficos
Autores principales: Carnevale, Joseph, Winston, Graham, Goldberg, Jacob, Brennan, Cameron, Tabar, Viviane, Moss, Nelson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401380/
http://dx.doi.org/10.1093/noajnl/vdaa073.038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401380/
http://dx.doi.org/10.1093/noajnl/vdaa073.038

Ejemplares similares